Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Share-based Compensation (2023 - 2025)

Incannex Healthcare (IXHL) has disclosed Share-based Compensation for 3 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 423.91% to -$2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.2 million through Dec 2025, down 169.9% year-over-year, with the annual reading at $2.6 million for FY2025, 70.78% down from the prior year.
  • Share-based Compensation hit -$2.3 million in Q4 2025 for Incannex Healthcare, up from -$2.6 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.7 million in Q4 2023 to a low of -$2.6 million in Q3 2025.
  • Historically, Share-based Compensation has averaged $484500.0 across 3 years, with a median of $107500.0 in 2023.
  • Biggest YoY gain for Share-based Compensation was 61.17% in 2025; the steepest drop was 472.11% in 2025.
  • Year by year, Share-based Compensation stood at $3.7 million in 2023, then tumbled by 111.85% to -$435000.0 in 2024, then crashed by 423.91% to -$2.3 million in 2025.
  • Business Quant data shows Share-based Compensation for IXHL at -$2.3 million in Q4 2025, -$2.6 million in Q3 2025, and $1.3 million in Q2 2025.